Remove 2024 Remove Documentation Remove Dosage
article thumbnail

State of Well-Being 2023-2024

The Happy PharmD

The stress experienced by community pharmacists compared to those in other settings is well-documented and has been a longstanding issue. The strain on pharmacists can lead to errors, as evidenced by a pharmacist who almost administered the wrong vaccine dosage due to workload pressures. Feel free to check it out!

article thumbnail

Pharmacists in Florida (and Elsewhere): Waive Prescribing Red Flags at Your Peril

FDA Law Blog: Biosimilars

DEA recently revoked the registration of Coconut Grove Pharmacy (“Coconut Grove”), like Gulf Med Pharmacy also in Florida, for its failure to resolve prescribing red flags and document such resolution. 50,372 , 50,377 (June 13, 2024). Coconut Grove Pharmacy; Decision and Order, 89 Fed. 50,372 at 50,372-73.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Recurrent drug shortages signal onerous outlook for cardiovascular care

Pharmaceutical Technology

According to the agency, shortages of both drugs are expected to last until 2024, as a result of growing demand. As of November 2, different dosage forms of the treatment remain on the FDA’s drug shortages list due to manufacturing challenges, with estimated recovery dates in March, June, and September 2023.

Dosage 111
article thumbnail

Court Grants Summary Judgment Ending AstraZeneca’s Lawsuit Challenging the IRA

Big Molecule Watch

Judge Connolly’s opinion follows an hours-long oral argument held on Jan.

article thumbnail

Herbs and Supplements

RX Note

A quick question: Do you know the common dosage of St. Fenugreek has been documented to have uterine stimulant effects and has been used in traditional medicine to induce childbirth. The situation is further complicated by the wide range of doses and preparations used in clinical studies. John's Wort or its typical uses?

article thumbnail

Price Limits, Affordability Boards, Penalties, Oh My: Minnesota Enacts Sweeping Drug Pricing Reforms

FDA Law Blog: Biosimilars

Initial appointments to both the Board and advisory council will occur by January 1, 2024. Prescription Drug Affordability Board The law also establishes a nine-member Prescription Drug Affordability Board and an 18-member stakeholder advisory council to provide advice to the Board on drug cost issues.

article thumbnail

The case for AI and machine learning in life sciences

Pharmaceutical Technology

GlobalData forecasts that the market for AI platforms for the entire healthcare industry will reach $4.3bn by 2024, up from $1.5bn in 2019 [i]. Consent documents often describe technical medical conditions and regulatory bodies are increasing pressure on sponsors to ensure that patient-facing information can be easily understood by patients.